|
Market Closed -
Nasdaq
16:00:00 2026-09-01 EDT
|
5-day change | 1st Jan Change | ||
| 149.92 USD | +2.45% |
|
+2.17% | +22.14% |
| 09-01 | Global pharma companies that have publicly announced Trump drug pricing agreements | RE |
| 08-28 | Warsh Takes the Stage |  |
| Market Cap | 186B 160B 151B 138B 258B 17,649B 260B 1,788B 694B 8,972B 698B 683B 29,782B | P/E 2026 * |
-45.8x | P/E 2027 * | 18.7x |
|---|---|---|---|---|---|
| Enterprise Value | 203B 175B 164B 150B 282B 19,239B 284B 1,949B 757B 9,780B 761B 744B 32,465B | EV / Sales 2026 * |
6.6x | EV / Sales 2027 * | 5.97x |
| Free-Float |
99.88% | Yield 2026 * |
2.2% | Yield 2027 * | 2.27% |
Last Transcript : Gilead Sciences, Inc.
| 1 day | +2.45% | ||
| 1 week | +2.17% | ||
| Current month | +2.45% | ||
| 1 month | +15.14% | ||
| 3 months | +11.52% | ||
| 6 months | +0.65% | ||
| Current year | +22.14% |
| 1 week | 143.18 |  | 149.96 |
| 1 month | 129.02 | | 149.96 |
| Current year | 116.88 | | 157.29 |
| 1 year | 108.46 | | 157.29 |
| 3 years | 62.07 | | 157.29 |
| 5 years | 57.16 | | 157.29 |
| 10 years | 56.56 | | 157.29 |
| Manager | Title | Age | Since |
|---|---|---|---|
Daniel O'Day
CEO | Chief Executive Officer | 61 | 2019-02-28 |
Andrew Dickinson
DFI | Director of Finance/CFO | 56 | 2019-10-31 |
Keeley Wettan
CMP | Compliance Officer | - | 2025-12-17 |
| Director | Title | Age | Since |
|---|---|---|---|
Kelly Kramer
BRD | Director/Board Member | 58 | 2016-08-18 |
| Director/Board Member | 73 | 2017-12-31 | |
Harish Manwani
BRD | Director/Board Member | 72 | 2018-05-08 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/26/26 | Exercice | Director | 54,000 | 0.0043% | ||
| 8/20/26 | Exercice | Director | 15,000 | 0.0012% | ||
| 8/17/26 | Exercice | Executive/Senior Manager | 78,000 | 0.0063% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.45% | +2.17% | +32.71% | +96.03% | 181B | |
| +0.28% | -6.97% | +58.34% | +109.31% | 1,031B | |
| +2.01% | -0.68% | +53.07% | +67.73% | 641B | |
| +1.39% | -1.71% | +23.57% | +76.91% | 453B | |
| -1.50% | -6.18% | +33.50% | +33.50% | 349B | |
| +6.25% | +3.31% | +29.46% | +46.64% | 290B | |
| -0.07% | -1.22% | +1.46% | +12.19% | 252B | |
| +1.92% | -1.29% | +52.28% | +70.91% | 232B | |
| +0.51% | -1.79% | -18.09% | -53.86% | 201B | |
| +0.32% | +2.07% | +15.31% | -19.30% | 162B | |
| Average | +1.21% | -2.50% | +28.16% | +44.01% | 379.2B | |
| Weighted average by Cap. | +1.10% | -3.73% | +37.54% | +63.07% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 30.69B 26.47B 24.91B 22.71B 42.64B 2,913B 42.94B 295B 115B 1,481B 115B 113B 4,916B | 32.68B 28.19B 26.52B 24.18B 45.41B 3,103B 45.72B 314B 122B 1,577B 123B 120B 5,235B |
| Net income | -4.27B -3.69B -3.47B -3.16B -5.94B -406B -5.98B -41.11B -15.97B -206B -16.05B -15.7B -685B | 10.28B 8.86B 8.34B 7.6B 14.28B 976B 14.38B 98.82B 38.38B 496B 38.58B 37.74B 1,646B |
| Net Debt | 16.75B 14.45B 13.59B 12.39B 23.27B 1,590B 23.43B 161B 62.54B 808B 62.87B 61.5B 2,683B | 9.12B 7.87B 7.41B 6.75B 12.68B 866B 12.77B 87.76B 34.08B 440B 34.26B 33.51B 1,462B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-01 | US$149.92 | +2.45% | 4,826,166 |
| 26-08-31 | US$146.34 | +0.45% | 6,594,694 |
| 26-08-28 | US$145.68 | -2.14% | 3,946,913 |
| 26-08-27 | US$148.86 | +0.52% | 5,014,794 |
| 26-08-26 | US$148.09 | -0.46% | 5,259,811 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GILD Stock
Select your edition
All financial news and data tailored to specific country editions
